Gene | Description | Differential expression in High dose | Differential expression in medium dose | Differential expression in Low dose | |||
---|---|---|---|---|---|---|---|
log2 Fold Change | padj | log2 Fold Change | padj | log2 Fold Change | Padj | ||
SLA-DQB1 | SLA-DQ beta1 domain | −1.36 | 4.51E-03 | −1.64 | 9.01E-04 | TND | TND |
SLA-DQA | MHC class II histocompatibility antigen SLA-DQA | −1.85 | 8.57E-04 | −1.19 | 3.97E-02 | TND | TND |
SLA-DRA | MHC class II DR-alpha | −1.62 | 5.34E-03 | TND | TND | TND | TND |
SLA-DRB1 | MHC class II histocompatibility antigen SLA-DRB1 | TND | TND | −1.20 | 4.72E-02 | TND | TND |
SLA-DOB | MHC class II, DO beta | TND | TND | −2.37 | 2.33E-03 | TND | TND |
SLA-DMB | MHC class II, DM beta | −1.67 | 1.84E-03 | −1.27 | 2.28E-02 | TND | TND |
SEL1L3 | SEL1L family member 3 | 1.59 | 4.11E-02 | TND | TND | TND | TND |
SEL1L | SEL1L adaptor subunit of ERAD E3 ubiquitin ligase | −2.13 | 1.43E-05 | −1.47 | 5.07E-03 | TND | TND |
PSME4 | Proteasome activator subunit 4 | −0.96 | 7.83E-03 | TND | TND | TND | TND |
PSMD4 | Proteasome 26S subunit, non-ATPase 4 | TND | TND | 1.29 | 3.23E-03 | TND | TND |
PSMD3 | Proteasome 26S subunit, non-ATPase 3 | 1.32 | 4.70E-03 | TND | TND | TND | TND |
PSMC5 | Proteasome 26S subunit, ATPase 5 | TND | TND | 0.89 | 2.78E-02 | TND | TND |
PSMC3 | Proteasome 26S subunit, ATPase 3 | TND | TND | 1.16 | 3.35E-02 | TND | TND |
PSMC1 | Proteasome 26S subunit, ATPase 1 | TND | TND | 1.10 | 2.25E-02 | TND | TND |
PMSF1 | Proteasome inhibitor subunit 1 | 0.98 | 3.08E-02 | 1.10 | 1.61E-02 | TND | TND |
CTSS | Cathepsin S | −2.10 | 5.96E-06 | −1.88 | 2.60E-04 | TND | TND |
ADRM1 | ADRM1 26S proteasome ubiquitin receptor | 1.20 | 1.60E-02 | TND | TND | TND | TND |